全文获取类型
收费全文 | 109315篇 |
免费 | 10538篇 |
国内免费 | 7753篇 |
专业分类
耳鼻咽喉 | 911篇 |
儿科学 | 1231篇 |
妇产科学 | 1215篇 |
基础医学 | 13097篇 |
口腔科学 | 2188篇 |
临床医学 | 14353篇 |
内科学 | 15774篇 |
皮肤病学 | 1307篇 |
神经病学 | 6056篇 |
特种医学 | 4341篇 |
外国民族医学 | 66篇 |
外科学 | 11805篇 |
综合类 | 19027篇 |
现状与发展 | 32篇 |
一般理论 | 6篇 |
预防医学 | 6746篇 |
眼科学 | 2937篇 |
药学 | 11079篇 |
100篇 | |
中国医学 | 5971篇 |
肿瘤学 | 9364篇 |
出版年
2024年 | 242篇 |
2023年 | 1810篇 |
2022年 | 2885篇 |
2021年 | 5822篇 |
2020年 | 4488篇 |
2019年 | 3822篇 |
2018年 | 3946篇 |
2017年 | 3682篇 |
2016年 | 3410篇 |
2015年 | 5240篇 |
2014年 | 6242篇 |
2013年 | 5710篇 |
2012年 | 8414篇 |
2011年 | 9242篇 |
2010年 | 5820篇 |
2009年 | 4549篇 |
2008年 | 5658篇 |
2007年 | 5905篇 |
2006年 | 5736篇 |
2005年 | 5656篇 |
2004年 | 3679篇 |
2003年 | 3424篇 |
2002年 | 2887篇 |
2001年 | 2346篇 |
2000年 | 2446篇 |
1999年 | 2689篇 |
1998年 | 1783篇 |
1997年 | 1680篇 |
1996年 | 1304篇 |
1995年 | 1135篇 |
1994年 | 964篇 |
1993年 | 646篇 |
1992年 | 773篇 |
1991年 | 652篇 |
1990年 | 586篇 |
1989年 | 507篇 |
1988年 | 420篇 |
1987年 | 373篇 |
1986年 | 285篇 |
1985年 | 226篇 |
1984年 | 118篇 |
1983年 | 98篇 |
1982年 | 63篇 |
1981年 | 63篇 |
1980年 | 47篇 |
1979年 | 51篇 |
1978年 | 10篇 |
1976年 | 8篇 |
1968年 | 6篇 |
1957年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Miao-Zhen Qiu Cai-Yun He Shi-Xun Lu Wen-Long Guan Fang Wang Xiao-Jian Wang Ying Jin Feng-Hua Wang Yu-Hong Li Jian-Yong Shao Zhi-Wei Zhou Jing-Ping Yun Rui-Hua Xu 《International journal of cancer. Journal international du cancer》2020,146(1):272-280
Epstein–Barr virus (EBV)-associated gastric carcinomas (EBVaGCs) may account for 8–9% of all gastric cancer (GC) patients. All previous reports on EBVaGC were retrospective. Prospective study is warranted to evaluate the exact role of EBV status in predicting the prognosis of GC. It is of special interest to figure out whether dynamic detection of plasma EBV-DNA load could be a feasible biomarker for the monitor of EBVaGC. From October 2014 to September 2017, we consecutively collected GC patients (n = 2,760) from Sun Yat-sen University Cancer Center for EBER examination. We detected EBV-DNA load in plasma and tissue samples of EBVaGC patients at baseline. Subsequently, plasma EBV-DNA load was dynamically monitored in EBVaGC patients. The overall prevalence of EBVaGC is 5.1% (140/2,760). The incidence rate of EBVaGC decreased with advanced AJCC 7th TNM stage (p < 0.001), with the corresponding percentages of 9.3, 9.9, 6.7 and 1.4% for Stage I, II, III and IV patients. EBVaGC patients were predominately young males with better histologic differentiation and earlier TNM stage than EBV-negative GC (EBVnGC) patients. EBVaGC patients were confirmed to had a favorable 3-year survival rate (EBVaGC vs. EBVnGC: 76.8% vs. 58.2%, p = 0.0001). Though only 52.1% (73/140) EBVaGC patients gained detectable EBV-DNA and 43.6% (61/140) reached a positive cutoff of 100 copies/ml, we found the plasma EBV-DNA load in EBVaGC decreased when patients got response, while it increased when disease progressed. Our results suggested that plasma EBV-DNA is a good marker in predicting recurrence and chemotherapy response for EBVaGC patients. 相似文献
82.
新型冠状病毒肺炎(corona virus disease 2019,COVID-19)自2019年12月爆发以来,由于具有高传染性,迅速在世界各地蔓延,国内外疫情防治形势空前严峻。COVID-19不仅造成肺部、肠道、肾脏等多脏器损害,且部分患者以眼表损害为首发或伴发症状出现,临床上很容易被忽视。COVID-19的眼表损害归属于祖国医学“天行赤眼”范畴,本文结合国内外最新的文献报道,探讨新型冠状病毒(2019 novel corona virus,2019-nCoV)对眼表的损害,阐明其可能机制,并从中西医角度提出可行的治疗措施。 相似文献
83.
Clinical and Translational Oncology - The specific association between PTEN deletion or ERG rearrangement and the recurrence of prostate cancer (PC) treated with radical prostatectomy (RP) or... 相似文献
84.
升降浮沉是中药理论体系的重要组成部分,后世医家分别从理论及临床应用方面加以阐发,不断充实升降浮沉理论,使其日臻成熟与完善。李东垣《脾胃论》所载补中益气汤,亦被后世奉为治疗“中气下陷”证的主方。张锡纯在《医学衷中参西录》中提出了“大气下陷”一词,并针对此证创立了专方升陷汤。两者同为“气陷”证而设,然其内涵又有不同。依据升降浮沉理论于脏腑、药物之用,通过补中益气汤与升陷汤的组方思路探析,比较治则治法之不同,分析其所治气陷证之别。升降浮沉理论贯穿于此二方的理论思想和制方用药方法,对充实、完善中药药性理论具有积极作用。 相似文献
85.
目的评估消化道恶性肿瘤患者的能量消耗,探讨最佳计算公式及能量消耗的影响因素。方法采用连续入组法,纳入2016年3月至2016年12月在陆军军医大学第一附属医院肿瘤科住院治疗患者,运用代谢车测定其静息代谢能量(REE),使用Harris-Benedict公式和30kcal/(kg·d) 公式预测患者的一日总能量消耗(TEE)。收集研究对象的相关指标如年龄、身高、体重、病程、原位癌部位、是否荷瘤等。结果共纳入26例患者,其中包括食管癌11例,胃癌8例,结直肠癌7例,73%的患者处于高代谢状态,约69%的患者处于肿瘤Ⅳ期;其中不同病程和原位癌位置与静息能量消耗有差异,差异具有统计学意义;用30kcal/(kg·d)×体重估算TEE可能并不适用于消瘦的消化道肿瘤患者。结论消化道恶性肿瘤患者大多存在营养不良且处于高代谢状态,在给消化道恶性肿瘤患者提供能量时应适当考虑病程长短、肿瘤分期以及肿瘤部位等因素。尽量使用代谢车估算恶性肿瘤患者的TEE,若没有代谢车条件时,对于能下床活动的消化道恶性肿瘤患者,体质指数(BMI)≥18.5kg/m2者推荐使用30kcal/(kg·d)×实际体重的方法估算TEE,BMI<18.5kg/m2者推荐使用30kcal/(kg·d)×标准体重的方法估算TEE。 相似文献
86.
87.
Toni Kulju Joonas Haapasalo Ryan Verner Maxine Dibu‐Adjei Kai Lehtimki Sirpa Rainesalo Jukka Peltola 《Neuromodulation》2020,23(6):852-858
BackgroundIn vagal nerve stimulation (VNS) therapy, the release of VNS model 106 (AspireSR) allowed for responsive VNS (rVNS). rVNS utilizes a cardiac-based seizure detection algorithm to detect seizure-induced tachycardia to trigger additional stimulation. There are some studies suggesting clinical benefits of rVNS over traditional VNS, but the performance and significance of autostimulation mode in clinical practice are poorly understood.ObjectivesTo assess the effect of initiation of rVNS therapy and altered stimulation settings on the number of daily stimulations and energy consumption in VNS therapy and to compare autostimulation performance in different epilepsy types.Materials and MethodsRetrospective follow-up of 30 patients with drug-resistant epilepsy treated with rVNS including 17 new implantations and 13 battery replaces at a single center in Finland. Our data consist of 208 different stimulation periods, that is, episodes with defined stimulation settings and both autostimulation and total stimulation performance-related data along with clinical follow-up.ResultsThe variation in autostimulation frequency was highly dependent on the duration of the OFF-time and autostimulation threshold (p < 0.05). There was a large additional effect of autostimulation mode on therapy time and energy consumption with longer OFF-times, but a minor effect with shorter OFF-times. Significantly more autostimulations were triggered in the temporal lobe and multifocal epilepsies than in extratemporal lobe epilepsies.ConclusionsThe initiation of autostimulation mode in VNS therapy increased the total number of stimulations. Shortening the OFF-time leads to a decreased number and share of automatic activations. Epilepsy type may affect autostimulation activity. 相似文献
88.
89.
90.
S. Xing X. Zhang J. H. Liu X. Huang P. Zhou 《Clinical and experimental immunology》2019,195(1):121-131
Recent experimental strategies to reduce graft-versus-host disease (GVHD) have focused largely on modifying innate immunity. Toll-like receptor (TLR)-driven myeloid differentiation primary response 88 (MyD88)-dependent signalling pathways that initiate adaptive immune function are also critical for the pathogenesis of GVHD. This study aimed to delineate the role of host MyD88 in the development of acute GVHD following fully major histocompatibility complex-mismatched allogeneic bone marrow transplantation (BMT). When myeloablated BALB/c MyD88 knock-out recipients were transplanted with C57BL/6 (B6) donor cells, they developed significantly more severe GVHD than wild-type (WT) BALB/c hosts. The increased morbidity and mortality in MyD88–/– mice correlated with increased serum levels of lipopolysaccharide and elevated inflammatory cytokines in GVHD target organs. Additionally, MyD88 deficiency in BMT recipients led to increased donor T cell expansion and more donor CD11c+ cell intestinal infiltration with apoptotic cells but reduced proliferation of intestinal epithelial cells compared with that in WT BMT recipients. Decreased expression of tight junction mRNA in epithelial cells of MyD88–/– mice suggested that MyD88 contributes to intestinal integrity. Cox-2 expression in the GVHD-targeted organs of WT mice is increased upon GVHD induction, but this enhanced expression was obviously inhibited by MyD88 deficiency. The present findings demonstrate an unexpected role for host MyD88 in preventing GVHD after allogeneic BMT. 相似文献